single dose epitope-based vaccine (Immunovaccine/La Jolla Institute of Allergy and Immunology)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namesingle dose epitope-based vaccine (Immunovaccine/La Jolla Institute of Allergy and Immunology)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIMV Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLa Jolla Institute For Allergy & ImmunologyIMV Inc
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A